Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Immunotoxin Therapy in Treating Patients With Advanced Cancer
| Conditions: | Cervical Cancer|Fallopian Tube Cancer|Head and Neck Cancer|Lung Cancer|Malignant Mesothelioma|Ovarian Cancer|Pancreatic Cancer|Peritoneal Cavity Cancer |
| Start Date: | December 1, 2000 |
| Phase: | Phase I |
| Status: | Completed |
| NCT ID: | NCT00006981 |
| Study Type: | Interventional |
| Intervention: | Biological: SS1(dsFv)-PE38 immunotoxin |
| Study Design: | Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | National Cancer Institute (NCI) |
| Ages: | Adult|Senior |
| Enrollment: | 0 |
| Funded By: | NIH |
| First Received: | December 6, 2000 |
| End Date: | |
| Last Updated: | January 9, 2010 |
| Last Verified: | May 1, 2005 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
